SCHEMBL28707229

SCHEMBL28707229

CNc1ccc(C(=O)N(CCCO)c2ccccn2)cc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 2/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PRKCI P41743 1/20 0.43
TSHR P16473 1/20 0.41
F2 P00734 3/20 0.41
HTR1A P08908 3/20 0.41
DRD4 P21917 3/20 0.41
SLC22A2 O15244 1/20 0.40
F10 P00742 1/20 0.40
PLG P00747 1/20 0.40
PLAT P00750 1/20 0.40
PROC P04070 1/20 0.40
HPN P05981 1/20 0.40
PRSS1 P07477 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29500798 1.00 SMN1; SMN2 (0.46) SMN1; SMN2HSD17B10ALDH1A1MAPK1MEN1
SCHEMBL17028812 0.89 F2 (0.46) SMN1; SMN2HSD17B10ALDH1A1MAPK1MEN1
SCHEMBL9926718 0.88 SMN1; SMN2 (0.51) SMN1; SMN2HSD17B10ALDH1A1MAPK1MEN1
SCHEMBL1269634 0.83 NQO2 (0.54) SMN1; SMN2HSD17B10ALDH1A1MAPK1MEN1
SCHEMBL27944294 0.83 SMN1; SMN2 (0.42) SMN1; SMN2HSD17B10ALDH1A1MAPK1MEN1
SCHEMBL12922436 0.83 SMN1; SMN2 (0.46) SMN1; SMN2HSD17B10ALDH1A1MAPK1MEN1
SCHEMBL30407813 0.83 NQO2 (0.54) SMN1; SMN2HSD17B10ALDH1A1MAPK1MEN1
SCHEMBL15150307 0.81 ALDH1A1 (0.48) SMN1; SMN2HSD17B10ALDH1A1MAPK1MEN1
SCHEMBL6776686 0.81 GAA (0.44) SMN1; SMN2HSD17B10ALDH1A1MAPK1MEN1
SCHEMBL15562826 0.81 TSHR (0.41) SMN1; SMN2HSD17B10ALDH1A1MAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110128407-B Preparation method of dabigatran etexilate key intermediate 连云港恒运药业有限公司 2022-04-01 CN disclosed